| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1210/EN.2003-0900 |
| P8608 | Fatcat ID | release_5ka2dacbzfbvfkmweirvqmgnda |
| P953 | full work available at URL | http://academic.oup.com/endo/article-pdf/144/10/4237/10376644/endo4237.pdf |
| https://academic.oup.com/endo/article-pdf/144/10/4237/10376644/endo4237.pdf | ||
| P698 | PubMed publication ID | 14500558 |
| P2093 | author name string | Donald P. McDonnell | |
| P2860 | cites work | An endocrine pathway in the prostate, ERbeta, AR, 5alpha-androstane-3beta,17beta-diol, and CYP7B1, regulates prostate growth | Q24536103 |
| Cloning of a novel receptor expressed in rat prostate and ovary | Q24607949 | ||
| Estrogen receptor (ER) beta, a modulator of ERalpha in the uterus | Q24681911 | ||
| Molecular basis of agonism and antagonism in the oestrogen receptor | Q27746278 | ||
| Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial | Q27860743 | ||
| Estrogen receptor null mice: what have we learned and where will they lead us? | Q28137633 | ||
| Connections and regulation of the human estrogen receptor | Q28201958 | ||
| Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta | Q28304508 | ||
| Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group | Q29615228 | ||
| Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites | Q29620551 | ||
| Peptide antagonists of the human estrogen receptor | Q30633677 | ||
| The Molecular Pharmacology of SERMs | Q33730355 | ||
| Evaluation of an Estrogen Receptor-β Agonist in Animal Models of Human Disease | Q34263880 | ||
| Effects of CP-336,156, a new, nonsteroidal estrogen agonist/antagonist, on bone, serum cholesterol, uterus and body composition in rat models | Q34746661 | ||
| Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium | Q35136963 | ||
| Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta. | Q36456030 | ||
| Estrogen receptor-alpha detected on the plasma membrane of aldehyde-fixed GH3/B6/F10 rat pituitary tumor cells by enzyme-linked immunocytochemistry | Q38322118 | ||
| Definition of the critical cellular components which distinguish between hormone and antihormone activated progesterone receptor. | Q40455173 | ||
| Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-alpha and estrogen receptor-beta: correlations with biological character and distinct differences among SRC coactivator family members | Q43507765 | ||
| Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists. | Q43517366 | ||
| Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease | Q43937255 | ||
| Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein | Q43984479 | ||
| Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators | Q43988923 | ||
| Characterization of the biological roles of the estrogen receptors, ERalpha and ERbeta, in estrogen target tissues in vivo through the use of an ERalpha-selective ligand | Q44193757 | ||
| An issue of tissues: divining the split personalities of selective estrogen receptor modulators | Q58055474 | ||
| Estrogen replacement and coronary artery disease. Effect on survival in postmenopausal women | Q68610300 | ||
| Estrogen replacement therapy and risk of fatal breast cancer in a prospective cohort of postmenopausal women in the United States | Q71546196 | ||
| The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens | Q73222352 | ||
| Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women | Q73911971 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endocrinology | Q162606 |
| P304 | page(s) | 4237-4240 | |
| P577 | publication date | 2003-10-01 | |
| P1433 | published in | Endocrinology | Q3054009 |
| P1476 | title | Mining the complexities of the estrogen signaling pathways for novel therapeutics | |
| Mining the Complexities of the Estrogen Signaling Pathways for Novel Therapeutics | |||
| P478 | volume | 144 |
| Q38317726 | A novel principle for partial agonism of liver X receptor ligands. Competitive recruitment of activators and repressors |
| Q33756323 | Altered pharmacology and distinct coactivator usage for estrogen receptor-dependent transcription through activating protein-1. |
| Q34603190 | Assessment of xenoestrogens using three distinct estrogen receptors and the zebrafish brain aromatase gene in a highly responsive glial cell system |
| Q36974411 | Comparative effects of dydrogesterone and medroxyprogesterone acetate in critical areas: the brain and the vessels |
| Q37828472 | Diagnosis and treatment of osteopenia |
| Q34161867 | Emerging therapeutic opportunities for skeletal restoration |
| Q35098363 | Estrogen receptor-1 (Esr1) and -2 (Esr2) regulate the severity of clinical experimental allergic encephalomyelitis in male mice |
| Q64967677 | Medical Treatment for Osteoporosis: From Molecular to Clinical Opinions. |
| Q34652138 | Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis |
| Q37081401 | No effect of different estrogen receptor ligands on cognition in adult female monkeys |
| Q36267925 | Nutritional flavonoids impact on nuclear and extranuclear estrogen receptor activities |
| Q36849023 | The Development of INT131 as a Selective PPARgamma Modulator: Approach to a Safer Insulin Sensitizer |
| Q36282652 | The application of BacMam technology in nuclear receptor drug discovery |
| Q38246517 | Treatment of post-menopausal osteoporosis: beyond bisphosphonates |
| Q34031994 | Update on Estrogens and the Skeleton |
Search more.